Alembic Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alembic Pharma from all sources in a single place.

Alembic Pharmaceuticals Ltd.

15 May 2026, 08:26PM

784.10

-0.20%

Company Update

Alembic Pharmaceuticals Ltd - 533573 - Alembic Pharmaceuticals Limited Passes ANVISA (Brazil) GMP Inspection For Its …

BSE India

Please find attached.

pdf

Alembic Pharmaceuticals Ltd.

15 May 2026, 08:06PM

784.10

-0.20%

Alembic Pharmaceuticals Q4 FY26 results: Net profit rises 29% at 202.7 cr

Business Standard

Alembic Pharmaceuticals Ltd on Friday reported a 29 per cent rise in consolidated net profit at Rs 202.7 crore in the fourth quarter ended March 31, driven by revenue growth across segments. The company had posted a consolidated net profit of Rs 156.89 crore in the corresponding period of previous fiscal, Alembic Pharmaceuticals said in a regulatory filing. Consolidated revenue from operations in the fourth quarter stood at Rs 1,847.72 crore as against Rs 1,769.64 crore in the year-ago period, it added. Total expenses in the quarter under review were at Rs 1,730.94 crore as compared to Rs 1,591.22 crore in the same period a year ago, the company said. Alembic Pharmaceuticals Ltd Managing Director Pranav Amin said,"Q4FY26 reflects disciplined execution across our businesses, supported by continued focus on profitability, operational delivery and long-term growth investments." He further said, "We delivered revenue growth across key segments while maintaining healthy pre-R&D...

Number of FII/FPI investors decreased from 195 to 188 in Mar 2026 qtr

Alembic Pharmaceuticals Q4 net profit rises 29% to Rs 202 crore

Business Line | 15 May 2026, 04:19PM

Alembic Pharmaceuticals Ltd.

15 May 2026, 06:28PM

784.10

-0.20%

Alembic Pharmaceuticals Results Earnings Call for Q4FY26 & Full Year

Conference Call with Alembic Pharmaceuticals Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Alembic Pharmaceuticals Ltd.

15 May 2026, 03:04PM

784.10

-0.20%

to see Rapid results content

Alembic Pharmaceuticals Ltd.

15 May 2026, 02:55PM

784.10

-0.20%

Company Update

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find attached.

pdf

Alembic Pharmaceuticals Ltd.

15 May 2026, 02:53PM

784.10

-0.20%

Investor Presentation

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find attached.

pdf

Alembic Pharmaceuticals Ltd.

15 May 2026, 02:51PM

784.10

-0.20%

Result

Alembic Pharmaceuticals Ltd - 533573 - Audited Financial Results For The Quarter And Financial Year Ended …

BSE India

Please fin enclosed herewith Audited Financial Results for the quarter and Financial Year ended 31st March, 2026.

pdf

	Mar 2026	Dec 2025	Mar 2025	Change QoQ%	Change YoY%
Total Revenue Qtr	1873.22	1891.81	1783.83	-1.0%	5.0%
Operating Profit Qtr	227.92	293.49	271.93	-22.3%	-16.2%
Net Profit Qtr	202.70	132.97	156.89	52.4%	29.2%
Earning Per Share Adjusted latest Qtr	10.31	6.76	7.98	52.5%	29.2%